Ribavirin

interferon alpha 1 ; Homo sapiens







377 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
251 15828854 Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis C. 2005 1
252 15850468 Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-alpha2b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia. 2005 May 1
253 15913800 Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C. 2005 Jul 4
254 16084622 HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin. 2005 Nov 1
255 16161954 [Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment]. 2005 May 1
256 16227297 Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. 2005 Nov 1
257 16237717 Recurrence of hepatitis C infection: Where are we now? 2005 Nov 1
258 16265606 New drug targets for HIV and hepatitis C virus coinfection. 2005 Jul 1 1
259 16279900 A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C. 2005 Nov 4
260 16381243 [Hepatitis C--treatment of untreated (naive) patients]. 2005 1
261 16433196 Interferon alpha monotherapy for chronic hepatitis C viral infection in thalassemics and hemodialysis patients. 2005 Dec 1
262 24764593 Combination therapy with pegylated interferon plus ribavirin in the treatment of hepatitis C virus-related thrombocytopenia. 2005 May 1
263 24790244 Clinical experience with nonstandard doses ofinterferon alfa-2b and ribavirin in the treatment of chronic hepatitis C infection: A retrospective analysis. 2005 Sep 4
264 14720084 Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations. 2004 3
265 14969836 A randomized trial of a 4- vs 12-week daily interferon dose regimen combined with ribavirin in treatment of patients with chronic hepatitis C. 2004 Feb 1
266 14988824 Antiviral action of ribavirin in chronic hepatitis C. 2004 Mar 6
267 15015227 [Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols]. 2004 Jan 3
268 15031779 Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha. 2004 Apr 1 1
269 15069622 High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load. 2004 1
270 15117324 Polymorphisms of NS5B protein relates to early clearance of hepatitis C virus by interferon plus ribavirin: a pilot study. 2004 May 1
271 15163430 Changes of HCV quasispecies during combination therapy with interferon and ribavirin. 2004 Jun 1
272 15185728 Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. 2004 Mar 1
273 15192274 A comparison of the exponential decay slope between PEG-IFN alfa-2b/ribavirin and IFN alfa-2b/ribavirin combination therapy in patients with chronic hepatitis C genotype 1b infection and a high viral load. 2004 1
274 15230850 Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options. 2004 Jul 2
275 15251366 Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study. 2004 Jun 1
276 15279546 Treatment of acute hepatitis C. 2004 1
277 15279549 Artificial neural networks for the prediction of response to interferon plus ribavirin treatment in patients with chronic hepatitis C. 2004 1
278 15309891 Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. 2004 Jun 4
279 15324941 Treatment of relapsers after combination therapy for chronic hepatitis C. 2004 Sep 4
280 15330905 Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT. 2004 Sep 1
281 15350490 Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. 2004 Jul-Aug 2
282 15357651 Effects of ribavirin combined with interferon-alpha 2b on viral kinetics during first 12 weeks of treatment in patients with hepatitis C virus genotype 1 and high baseline viral loads. 2004 Sep 1
283 15500548 Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA. 2004 Nov 1
284 15500555 A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone. 2004 Nov 1
285 15566510 Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan. 2004 Dec 2
286 15571424 Interleukin-2 plus ribavirin versus interferon-alpha-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-alpha-2b treatment. 2004 1
287 12614467 Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C. 2003 Mar 2
288 12691700 Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. 2003 May 4
289 12700452 Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. 2003 May 2 1
290 12702132 T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin. 2003 Apr 1
291 12719586 Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells. 2003 May 5
292 12734046 Pediatric issues in new therapies for hepatitis B and C. 2003 Jun 1
293 12753337 A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1. 2003 May 2
294 12753338 Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial. 2003 May 2
295 12753339 High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy. 2003 May 1
296 12753341 Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study. 2003 May 1
297 12772791 Combination treatment of IFNalpha2b and ribavirin in patients with chronic hepatitis C and persistently normal ALTs. 2003 May 1
298 12875209 [Trial of intraventricular ribavirin and interferon-alpha combination therapy for subacute sclerosing panencephalitis (SSPE) in Japan]. 2003 Jul 1
299 12910808 [Recent trends in the therapy of hepatitis C]. 2003 May-Jun 3
300 12934167 Clinical trial results of peginterferons in combination with ribavirin. 2003 2